Conference Coverage
-
Conference Coverage
Telemedicine for headache visits had high patient satisfaction
Most patients who used telemedicine said they would like to continue using it after the pandemic, though the study also revealed barriers to care...
-
Conference Coverage
Combination therapy may benefit patients with migraine
A retrospective chart review suggests adding an anti-CGRP antibody to onabotulinumtoxinA boosts benefit.
-
Conference Coverage
Bariatric surgery tied to 22% lower 5-year stroke risk
This study contributes to knowledge that suggests that reduction in ischemic stroke risk is yet another benefit of bariatric surgery, says a study...
-
Conference Coverage
No increased risk of hypertension with erenumab?
The rate of hypertension adverse events in postmarketing data was 0.144 per 100 person-years.
-
Conference Coverage
BBB integrity linked to cortical spreading depression
A model blood-brain barrier system suggests reorganization of proteins leads to loss of integrity after a simulated CSD event.
-
Conference Coverage
Insomnia in children tied to mood and anxiety disorders in adulthood
“Our findings further reinforce the need for early sleep interventions to prevent future mental health disorders,” researchers say.
-
Conference Coverage
Is trouble falling asleep a modifiable risk factor for dementia?
More frequent trouble falling asleep was predictive of poorer episodic memory, executive function, language, processing speed, and visuospatial...
-
Conference Coverage
COVID-19 vaccines are safe and effective for patients with migraine
The only real clinical concern clinicians may need to consider is the headache differential for women under age 60 who call with a headache a week...
-
Conference Coverage
Novel NSAID–triptan drug effectively relieves migraine pain
About 74% of patients who received AXS-07 experienced no progression of pain from 2 to 24 hours.
-
Conference Coverage
Excessive drooling is a sign of greater dysfunction in patients with Parkinson’s disease
“Sialorrhea is not just a cosmetic problem.”
-
Conference Coverage
Noted ability of Mozart’s music to reduce seizures explained?
The acoustic characteristics of Mozart’s Sonata for Two Pianos in D Major (K448) suppresses brain activity in patients with epilepsy.
Literature Review
-
Literature Review
Potential first-in-class, targeted therapy for myasthenia gravis
Results from the phase 3, randomized, placebo-controlled ADAPT trial showed reductions in disease burden and improvements in strength and quality...
-
From the Journals
Magnesium is strongly tied to lower risk for intracranial aneurysm
The effects may be partially mediated by magnesium’s influence on systolic blood pressure.
-
Literature Review
Is walking speed following stroke a good predictor of recovery?
Training enabled both “good” and “limited” walkers to increase travel distance during a 2-minute walk.
-
Literature Review
Updated consensus statement assesses new migraine treatments
The AHS offers a consensus statement, but not everyone agrees.
Latest News
-
Feature
New data on COVID-19’s cognitive fallout
“Low levels of oxygen in the brain could lead to confusion, headache, and brain fog, and cause the cognitive disturbances that we see.”
-
From the Journals
Depression remains common among dystonia patients
Use of antidepressants and CBT as a way to target negative body concept or social stigma are “underexplored and underutilized,” reported Dr. Alex...
-
From the Journals
No overall statin effect seen on dementia, cognition in ASPREE analysis
Still, there was an inconclusive link between statins and incident Alzheimer’s dementia in one subgroup of patients in the trial; researchers...
-
From the Journals
Profound brain changes found in patients who died of COVID-19
“The signature the virus leaves in the brain speaks of strong inflammation and disrupted brain circuits.”
-
From the Journals
Two case reports identify Guillain-Barré variants after SARS-CoV-2 vaccination
Investigators in India and the United Kingdom describe rare presentations of Guillain-Barré syndrome marked by facial paralysis, but evidence of...
FDA/CDC
-
FDA/CDC
FDA fast-tracks lecanemab for Alzheimer’s disease
The drug is a humanized monoclonal antibody that selectively binds to large, soluble aggregated Abeta protofibrils.
-
FDA/CDC
FDA updates label for controversial Alzheimer’s drug aducanumab (Aduhelm)
Revised labeling emphasizes that the drug should only be used in patients with the earliest stages of disease.
-
FDA/CDC
FDA head calls for investigation into agency’s approval of aducanumab (Aduhelm)
An independent investigation will examine whether anything occurred that was “inconsistent with FDA policies and procedures.”
Hitting a Nerve
-
Hitting a Nerve
A ‘minor’ gesture to protect my patients
Continuing to wear a mask provides some protection for me, and it provides some protection for my patients.